Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation
@article{Pongrcz2013ReversalON,
title={Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation},
author={Adrienn Pongr{\'a}cz and Szil{\'a}rd Szatm{\'a}ri and R{\'e}ka Nemes and B{\'e}la F{\"u}lesdi and Ed{\"o}m{\'e}r Tassonyi},
journal={Anesthesiology},
year={2013},
volume={119},
pages={36–42}
}Background:Doses of sugammadex required to reverse deep, moderate, and shallow rocuronium-induced neuromuscular blockade have been established. However, no adequate doses for the reversal of reappearance of four twitches of train-of-four (TOF) stimulation (threshold TOF-count-four) have been established. Methods:This single-center, randomized, controlled, double-blind, four-groups parallel-arm study included 80 patients undergoing general anesthesia with propofol, sevoflurane, fentanyl, and…
Topics from this paper
64 Citations
Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial
- MedicineAnesthesiology
- 2017
Sugammadex, in doses of 1.0 and 2.0 mg/kg, properly reversed a threshold train-of-four count of four vecuronium-induced block but did not prevent reparalysis.
Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,.
- MedicineBritish journal of anaesthesia
- 2016
In the conditions studied, substantially lower doses of sugammadex than the approved dose of 2.0 mg kg(-1) may be sufficient to reverse residual rocuronium-induced neuromuscular block at a recovery of TOFR≥0.2.
Sugammadex and Neostigmine Dose-Finding Study for Reversal of Residual Neuromuscular Block at a Train-of-Four Ratio of 0.2 (SUNDRO20)
- Medicine
- 2016
A residual neuromuscular block of a TOFR of 0.2 cannot be reversed reliably with neostigmine within 10 min, and substantially lower doses of sugammadex than the approved dose of 2.0 mg kg may be sufficient to reverse residual rocuronium-induced neuromUScular block at a recovery of TOFR≥0.2.
Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial
- MedicineAnesthesia and analgesia
- 2015
Sugammadex adequately and rapidly reverses pipecuronium-induced moderate NMB during sevoflurane anesthesia and the doses required to achieve reversal are investigated.
Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium-induced Neuromuscular Block in Patients Pretreated with Intravenous Magnesium: A Randomized Controlled Trial
- MedicineAnesthesiology
- 2014
Pretreatment with a single intravenous dose of MgSO4 60 mg/kg does not decrease the efficacy of recommended doses of sugammadex for the reversal of a moderate and deep neuromuscular block induced by an intubation dose of rocuronium.
Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3
- MedicineClinical and translational science
- 2021
The aims of the present study were to find suitable doses of sugammadex and neostigmine to reverse a residual vecuronium‐induced NMB from a time of flight (TOF) ratio of 0.3–0.9 and evaluate their safety and efficacy, and to find an appropriate statistical model to explore the suitable doses.
Sugammadex after the reappearance of four twitches during train-of-four stimulation: monitoring and dose considerations.
- MedicineAnesthesiology
- 2014
This is the first clinical trial that has considered a TOF ratio of 1.0, instead of 0.9 or greater, as the goal for reversal of NMB, and it is hoped that future research and clinical practice will follow the example shown by Pongrácz et al.1 by insisting on the use of this ratio as thegoal for NMB reversal.
Reversal of Rocuronium Induced Neuromuscular Block with Sugammadex or Neostigmine in Patients Undergoing Uvulopalatopharyngoplasty
- Medicine
- 2017
Comparison of the efficacy of reversal of neuromuscular blockade produced by rocuronium either by neostigmine or sugammadex using train of four ratio (TOF) found a statistically significant difference, however there was no significant difference regarding intraoperative complications, intraoperative laryngeal view, successful extubation, reintubations, and failure of extubations in both groups.
A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal
- Medicine, BiologyJournal of Anesthesia
- 2016
The aim of this study was to investigate the relationship between the dose of rocuronium needed to re-establish neuromuscular block and the time interval between sugammadex administration and re-administration of roCuronium.
Appropriate dosing of sugammadex to reverse deep rocuronium‐induced neuromuscular blockade in morbidly obese patients
- Medicine, BiologyAnaesthesia
- 2016
In morbidly obese patients, 4 mg.kg−1 of ideal body weight of sugammadex allows suitable reversal of deep rocuronium‐induced neuromuscular blockade and monitoring remains essential to detect residual curarisation or recurarisation.
References
SHOWING 1-10 OF 29 REFERENCES
Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding Agent
- MedicineAnesthesiology
- 2007
A dose–response relation was observed with sugammadex for reversal of both rocur onium- and vecuronium-induced neuromuscular block and was well tolerated.
Sugammadex Provides Faster Reversal of Vecuronium-Induced Neuromuscular Blockade Compared with Neostigmine: A Multicenter, Randomized, Controlled Trial
- Medicine, BiologyAnesthesia and analgesia
- 2010
Sugammadex provided significantly faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine and no serious adverse events or unexpected side effects were reported with either drug.
Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular Block
- MedicineAnesthesiology
- 2010
Sugammadex and neostigmine effectively and comparably reverse a rocuronium-induced shallow residual neuromuscular block at a train-of-four (TOF) ratio of 0.5.
Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex: A Dose-finding and Safety Study
- Medicine, BiologyAnesthesiology
- 2006
At doses of 2.0mg/kg or greater, sugammadex safely reversed 0.6 mg/kg rocuronium–induced neuromuscular block in a dose-dependent manner and was safe and well tolerated.
Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial
- MedicineEuropean journal of anaesthesiology
- 2010
Sugammadex achieved significantly faster recovery of neuromuscular function after rocuronium to a TOF ratio of 0.9 compared with neostigmine (Clinicaltrials.gov identifier: NCT00451217).
Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or Sevoflurane
- Biology, MedicineAnesthesia and analgesia
- 2007
The 95% confidence interval for the difference in recovery time between the 2 groups was well within the predefined equivalence interval, indicating that recovery from NMB was unaffected by maintenance anesthesia, and the safety profile of sugammadex was somewhat more favorable under propofol than under sevoflurane anesthesia.
Reversal of Profound Rocuronium-induced Blockade with Sugammadex: A Randomized Comparison with Neostigmine
- MedicineAnesthesiology
- 2008
Recovery from profound rocuronium-induced neuromuscular blockade was significantly faster with sugammadex versus with neostigmine, suggesting that sugamadex has a unique ability to rapidly reverse profound roCuronium neuromUScular blockade.
Reversal of Rocuronium-induced (1.2 mg/kg) Profound Neuromuscular Block by Sugammadex: A Multicenter, Dose-finding and Safety Study
- MedicineAnesthesiology
- 2007
Sugammadex rapidly and effectively reversed profound rocuronium-induced profound neuromuscular blockade in humans and was well tolerated.
Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine–Glycopyrrolate and Edrophonium–Atropine
- Medicine, BiologyAnesthesia and analgesia
- 2007
Sugammadex, 4 mg/kg IV, more rapidly and effectively reversed residual neuromuscular blockade when compared with neostigmine-glycopyrrolate group and edrophonium (1 mg/ kg IV), which was associated with less frequent dry mouth than that with the currently used reversal drug combinations.
Neostigmine antagonism of rocuronium block during anesthesia with sevoflurance, isoflurane or propofol
- MedicineCanadian journal of anaesthesia = Journal canadien d'anesthesie
- 2001
The continued administration of sevoflurane, and to a smaller extent isoflURane, results in delay in attaining adequate antagonism of rocuronium induced neuromuscular block.